Bastiaan Sallevelt

130 CHAPTER 2.3 References 1. K. Barnett, S.W. Mercer, M. Norbury, G. Watt, S. Wyke, B. Guthrie, Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study., Lancet (London, England). 380 (2012) 37–43. doi:10.1016/S01406736(12)60240-2. 2. A. Menotti, I. Mulder, A. Nissinen, S. Giampaoli, E.J. Feskens, D. Kromhout, Prevalence of morbidity and multimorbidity in elderly male populations and their impact on 10year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly)., J. Clin. Epidemiol. 54 (2001) 680–686. 3. R.L. Howard, A.J. Avery, S. Slavenburg, S. Royal, G. Pipe, P. Lucassen, M. Pirmohamed, Which drugs cause preventable admissions to hospital? A systematic review., Br. J. Clin. Pharmacol. 63 (2007) 136–147. doi:10.1111/j.1365-2125.2006.02698.x. 4. A.J. Leendertse, A.C.G. Egberts, L.J. Stoker, P.M.L.A. van den Bemt, Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands., Arch. Intern. Med. 168 (2008) 1890–1896. doi:10.1001/archinternmed.2008.3. 5. M.H. Beers, Explicit criteria for determining potentially inappropriate medication use by the elderly. An update., Arch. Intern. Med. 157 (1997) 1531–1536. 6. J.T. Hanlon, M.B. Artz, C.F. Pieper, C.I. Lindblad, R.J. Sloane, C.M. Ruby, K.E. Schmader, Inappropriate medication use among frail elderly inpatients., Ann. Pharmacother. 38 (2004) 9–14. doi:10.1345/aph.1D313. 7. A.C. Drenth-van Maanen, A.J. Leendertse, P.A.F. Jansen, W. Knol, C.J.P.W. Keijsers, M.C. Meulendijk, R.J. van Marum, The Systematic Tool to Reduce Inappropriate Prescribing (STRIP): Combining implicit and explicit prescribing tools to improve appropriate prescribing., J. Eval. Clin. Pract. 24 (2018) 317–322. doi:10.1111/jep.12787. 8. P. Gallagher, C. Ryan, S. Byrne, J. Kennedy, D. O’Mahony, STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation., Int. J. Clin. Pharmacol. Ther. 46 (2008) 72–83. 9. H. Hamilton, P. Gallagher, C. Ryan, S. Byrne, D. O’Mahony, Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients., Arch. Intern. Med. 171 (2011) 1013–1019. doi:10.1001/ archinternmed.2011.215. 10. B. Hill-Taylor, I. Sketris, J. Hayden, S. Byrne, D. O’Sullivan, R. Christie, Application of the STOPP/START criteria: a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact., J. Clin. Pharm. Ther. 38 (2013) 360–372. doi:10.1111/jcpt.12059. 11. P.F. Gallagher, M.N. O’Connor, D. O’Mahony, Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteria., Clin. Pharmacol. Ther. 89 (2011) 845–854. doi:10.1038/clpt.2011.44. 12. M.N. O’Connor, D. O’Sullivan, P.F. Gallagher, J. Eustace, S. Byrne, D. O’Mahony, Prevention of Hospital-Acquired Adverse Drug Reactions in Older People Using Screening Tool of Older Persons’ Prescriptions and Screening Tool to Alert to Right Treatment Criteria: A Cluster Randomized Controlled Trial., J. Am. Geriatr. Soc. 64 (2016) 1558–1566. doi:10.1111/jgs.14312. 13. D. O’Mahony, D. O’Sullivan, S. Byrne, M.N. O’Connor, C. Ryan, P. Gallagher, STOPP/ START criteria for potentially inappropriate prescribing in older people: version 2., Age Ageing. 44 (2015) 213–218. doi:10.1093/ageing/afu145.